{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:09:01Z","timestamp":1764079741014,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.mrgentox.2022.503445","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T20:28:58Z","timestamp":1642019338000},"page":"503445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The evaluation of the efficacy and potential genotoxic hazard of combined SAHA and 5-FU treatment in the chemoresistant colorectal cancer cell lines"],"prefix":"10.1016","volume":"874-875","author":[{"given":"Lucia","family":"B\u00e1lintov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslava","family":"Mat\u00fa\u0161kov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2674-2737","authenticated-orcid":false,"given":"Alena","family":"G\u00e1belov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrgentox.2022.503445_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111821","article-title":"Personalized medicine: stem cell in colorectal cancer treatment","volume":"141","author":"Patsalias","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mrgentox.2022.503445_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107447","article-title":"5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future","volume":"206","author":"Vodenkova","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.mrgentox.2022.503445_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111285","article-title":"5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: implication of DNA repair inhibition","volume":"137","author":"Sethy","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mrgentox.2022.503445_bib0020","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3390\/molecules13081551","article-title":"5-Fluorouracil: mechanisms of resistance and reversal strategies","volume":"13","author":"Zhang","year":"2008","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.mrgentox.2022.503445_bib0025","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.3892\/ol.2017.6512","article-title":"5FU resistance caused by reduced fluoro-deoxyuridine monophosphate and its reversal using deoxyuridine","volume":"14","author":"Mori","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.mrgentox.2022.503445_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081817","article-title":"Establishment and characterization of 5-fluorouracil-resistant human colorectal cancer stem-like cells: tumor dynamics under selection pressure","volume":"20","author":"Francipane","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.mrgentox.2022.503445_bib0035","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2174\/0929867324666170111152436","article-title":"Colorectal cancer chemotherapy: the evolution of treatment and new approaches","volume":"24","author":"McQuade","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.mrgentox.2022.503445_bib0040","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1053\/j.gastro.2015.07.011","article-title":"Epigenetic alterations in colorectal cancer: emerging biomarkers","volume":"149","author":"Okugawa","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mrgentox.2022.503445_bib0045","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s12253-019-00663-8","article-title":"Histone modifications and their role in colorectal cancer (review)","volume":"26","author":"Qin","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.mrgentox.2022.503445_bib0050","article-title":"Synergistic enhancement of cancer therapy using HDAC inhibitors: opportunity for clinical trials","volume":"11","author":"Prieto","year":"2020","journal-title":"Front. Genet."},{"issue":"3","key":"10.1016\/j.mrgentox.2022.503445_bib0055","doi-asserted-by":"crossref","first-page":"305","DOI":"10.17219\/acem\/66207","article-title":"Deregulated expression of HDAC3 in colorectal cancer and its clinical significance","volume":"27","author":"Nemati","year":"2018","journal-title":"Adv. Clin. Exp. Med."},{"issue":"6","key":"10.1016\/j.mrgentox.2022.503445_bib0060","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/med.21437","article-title":"The search for potent, small-molecule HDACIs in cancer treatment: a decade after vorinostat","volume":"37","author":"Zagni","year":"2017","journal-title":"Inc. Med. Res. Rev."},{"issue":"10","key":"10.1016\/j.mrgentox.2022.503445_bib0065","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.mrgentox.2022.503445_bib0070","article-title":"Targeting histone deacetylases: development of vorinostat for the treatment of cancer","volume":"2","author":"Richon","year":"2010","journal-title":"Future Med."},{"issue":"4","key":"10.1016\/j.mrgentox.2022.503445_bib0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4103\/0019-5154.160511","article-title":"Vorinostat- an overview","volume":"60","author":"Bubna","year":"2015","journal-title":"Indian J. Dermatol."},{"issue":"1","key":"10.1016\/j.mrgentox.2022.503445_bib0080","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.fct.2017.07.022","article-title":"Role of epigenome in tumorigenesis and drug resistance","volume":"109","author":"Hu","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.mrgentox.2022.503445_bib0085","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/mc.22852","article-title":"A452, an HDAC6-selective inhibitor, synergistically enhances the anticancer activity of chemotherapeutic agents in colorectal cancer cells","volume":"57","author":"Won","year":"2018","journal-title":"Mol. Carcinog."},{"issue":"1","key":"10.1016\/j.mrgentox.2022.503445_bib0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7150\/jca.16655","article-title":"Histone deacetylase inhibitor SAHA as potential targeted therapy agent for larynx cancer cells","volume":"8","author":"Grabarska","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.mrgentox.2022.503445_bib0095","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3892\/ijo.2015.3240","article-title":"Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines","volume":"48","author":"Asgar","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.mrgentox.2022.503445_bib0100","doi-asserted-by":"crossref","first-page":"9347","DOI":"10.1007\/s13277-015-3497-9","article-title":"Suberoylanilide hydroxamic acid enhances chemosensitivity to 5-fluorouracil in hepatocellular carcinoma via inhibition of thymidylate synthase","volume":"36","author":"Liao","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.mrgentox.2022.503445_bib0105","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1158\/1535-7163.MCT-18-1117","article-title":"Vorinostat potentiates 5-fluorouracil\/cisplatin combination by inhibiting chemotherapy-induced EGFR nuclear translocation and increasing cisplatin uptake","volume":"18","author":"Piro","year":"2019","journal-title":"Mol. Cancer Ther."},{"issue":"9","key":"10.1016\/j.mrgentox.2022.503445_bib0110","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4161\/cbt.8.9.8118","article-title":"Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or raltitrexed","volume":"8","author":"Gennaro","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.mrgentox.2022.503445_bib0115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ijc.24403","article-title":"Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells","volume":"125","author":"Fazzone","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.mrgentox.2022.503445_bib0120","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.3390\/cancers12123527","article-title":"SAHA overcomes 5-FU resistance in IFIT2-depleted oral squamous cell carcinoma cells","volume":"12","author":"Regmi","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.mrgentox.2022.503445_bib0125","first-page":"119","article-title":"Different responses to 5-fluoraouracil in mutagenicity and gene expression between two human lymphoblastoid cell lines with or without TP53 mutation","volume":"66","author":"Oka","year":"2012","journal-title":"Acta Med."},{"issue":"1","key":"10.1016\/j.mrgentox.2022.503445_bib0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cmdc.201500486","article-title":"Why hydroxamates may not be the best histone deacetylase inhibitors-what some may have forgotten or would rather forget?","volume":"11","author":"Shen","year":"2016","journal-title":"ChemMedChem"},{"issue":"3","key":"10.1016\/j.mrgentox.2022.503445_bib0135","doi-asserted-by":"crossref","DOI":"10.1002\/em.2850260309","article-title":"Evaluation of the micronucleus test in vitro using chinese hamster cells: results of four chemicals weakly positive in the in vivo micronucleus test","volume":"26","author":"Miller","year":"1995","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrgentox.2022.503445_bib0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0165-1218(97)00050-5","article-title":"The primary rat hepatocyte micronucleus assay: general features","volume":"392","author":"Eckl","year":"1997","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2022.503445_bib0145","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1073\/pnas.89.12.5408","article-title":"Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor \u03b21","volume":"89","author":"Oberhammer","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"33","key":"10.1016\/j.mrgentox.2022.503445_bib0150","doi-asserted-by":"crossref","first-page":"14639","DOI":"10.1073\/pnas.1008522107","article-title":"Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair","volume":"107","author":"Lee","year":"2010","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.mrgentox.2022.503445_bib0155","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/mutage\/gex002","article-title":"The next three decades of the comet assay: a report of the 11th International Comet Assay Workshop","volume":"32","author":"Koppen","year":"2017","journal-title":"Mutagenesis"},{"issue":"3","key":"10.1016\/j.mrgentox.2022.503445_bib0160","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/mutage\/gem051","article-title":"The comet assay: topical issues","volume":"23","author":"Collins","year":"2008","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrgentox.2022.503445_bib0165","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mrgentox.2018.05.011","article-title":"Molecular cytogenetics of the micronucleus: still surprising","volume":"836","author":"Russo","year":"2018","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"issue":"1\u20132","key":"10.1016\/j.mrgentox.2022.503445_bib0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-1218(97)00042-6","article-title":"The in vitro micronucleus test: a multi-endpoint assay to detect simultaneously mitotic delay, apoptosis, chromosome breakage, chromosome loss and non-disjunction","volume":"392","author":"Volders","year":"1997","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.mrgentox.2022.503445_bib0175","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1248\/bpb.b17-00439","article-title":"Different schedule-dependent effects of epigenetic modifiers on cytotoxicity by anticancer drugs in colorectal cancer cells","volume":"40","author":"Hosokawa","year":"2017","journal-title":"Biol. Pharm. Bull."},{"issue":"11","key":"10.1016\/j.mrgentox.2022.503445_bib0180","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-09-3028","article-title":"Inhibition of histone deacetylase in cancer cells slows down replication forks, activates dormant origins, and induces DNA damage","volume":"70","author":"Conti","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.mrgentox.2022.503445_bib0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1091581809352111","article-title":"Nonclinical safety assessment of the histone deacetylase inhibitor vorinostat","volume":"29","author":"Kerr","year":"2010","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.mrgentox.2022.503445_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152507","article-title":"Vorinostat is genotoxic and epigenotoxic in the mouse bone marrow cells at the human equivalent doses","volume":"441","author":"Attia","year":"2020","journal-title":"Toxicology"},{"key":"10.1016\/j.mrgentox.2022.503445_bib0195","first-page":"673","article-title":"DNA damage signaling in response to 5-fluorouracil in three colorectal cancer cell lines with different mismatch repair and TP53 status","volume":"39","author":"Adamsen","year":"2011","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.mrgentox.2022.503445_bib0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1248\/bpb.b13-00574","article-title":"Different effects of epigenetic modifiers on the cytotoxicity induced by 5-fluorouracil, irinotecan or oxaliplatin in colon cancer cells","volume":"37","author":"Ikehata","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.mrgentox.2022.503445_bib0205","first-page":"281","article-title":"Epigenetic regulation of susceptibility to anti-cancer drugs in HSC-3 cells","author":"Suzuki","year":"2007","journal-title":"Interface Oral Health Sci."},{"key":"10.1016\/j.mrgentox.2022.503445_bib0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mrrev.2017.02.002","article-title":"Fate of micronuclei and micronucleated cells","volume":"771","author":"Hintzsche","year":"2017","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2022.503445_bib0215","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00280-009-1236-x","article-title":"A phase I\/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapy","volume":"65","author":"Wilson","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.mrgentox.2022.503445_bib0220","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.currproblcancer.2018.03.001","article-title":"The role of epigenetic therapies in colorectal cancer","volume":"42","author":"Baretti","year":"2018","journal-title":"Curr. Probl. Cancer"},{"issue":"354","key":"10.1016\/j.mrgentox.2022.503445_bib0225","article-title":"Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-fluorouracil and perfluorocarbon","volume":"20","author":"Wu","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.mrgentox.2022.503445_bib0230","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"1\u20132","key":"10.1016\/j.mrgentox.2022.503445_bib0235","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0165-1218(95)90089-6","article-title":"The suitability of the micronucleus assay in human lymphocytes as a new biomarker of excision repair","volume":"342","author":"Surrall\u00e9s","year":"1995","journal-title":"Mutat. Res. Genet. Toxicol."},{"key":"10.1016\/j.mrgentox.2022.503445_bib0240","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1038\/s41596-020-0398-1","article-title":"Minimum Information for Reporting on the Comet Assay (MIRCA): recommendations for describing comet assay procedures and results","volume":"15","author":"Moller","year":"2020","journal-title":"Nat. Protoc."},{"issue":"1\u20132","key":"10.1016\/j.mrgentox.2022.503445_bib0245","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mrgentox.2006.03.002","article-title":"Reliable Comet assay measurements for detecting DNA damage induced by ionising radiation and chemicals","volume":"605","author":"Kumaravel","year":"2006","journal-title":"Mutat. Res."},{"issue":"3","key":"10.1016\/j.mrgentox.2022.503445_bib0250","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1385\/MB:26:3:249","article-title":"The comet assay for DNA damage and repair: principles, applications, and limitations","volume":"26","author":"Collins","year":"2004","journal-title":"Mol. Biotechnol."}],"container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571822000067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571822000067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:07:06Z","timestamp":1761300426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383571822000067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":50,"alternative-id":["S1383571822000067"],"URL":"https:\/\/doi.org\/10.1016\/j.mrgentox.2022.503445","relation":{},"ISSN":["1383-5718"],"issn-type":[{"type":"print","value":"1383-5718"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evaluation of the efficacy and potential genotoxic hazard of combined SAHA and 5-FU treatment in the chemoresistant colorectal cancer cell lines","name":"articletitle","label":"Article Title"},{"value":"Mutation Research\/Genetic Toxicology and Environmental Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrgentox.2022.503445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"503445"}}